Predicting lymph node spread in thyroid cancer with a new scale
Part of Cancer, Hormones & metabolism clinical trials.
This trial is testing a new scale to predict if thyroid cancer has spread to nearby lymph nodes. It may help doctors decide on the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with papillary thyroid cancer.
- You are between 16 and 80 years old.
- You are awake and able to talk clearly.
- Your cancer was not found to be another type (like medullary or undifferentiated).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tissue samples from people who had surgery for medullary thyroid cancer to see if certain features can predict whether the cancer has spread to nearby lymph nodes. This could help doctors better plan treatment and avoid unnecessary surgeries in the future.
This study uses artificial intelligence to look at ultrasound images and lymph node samples from people with thyroid cancer. The goal is to see if the AI can help predict whether cancer has spread to lymph nodes, which may guide treatment decisions.
This trial compares two types of neck surgery for people with papillary thyroid cancer that has spread to a small number of lymph nodes in the neck. The goal is to see if a less extensive lymph node removal works just as well as the standard more extensive surgery.
This study looks at tissue and blood samples (called a multiomics study) to understand why some small papillary thyroid cancers spread to lymph nodes in the neck. If you join, researchers will analyze your samples and ultrasound images to find patterns that might help predict lymph node spread, which could guide future treatment decisions.
This trial uses contrast-enhanced ultrasound before surgery to see if it can predict whether cancer has spread to lymph nodes in patients with early-stage papillary thyroid cancer. The goal is to improve treatment planning without unnecessary surgery.
This trial tests whether it is safe to avoid immediate surgery and instead monitor small thyroid cancers that are considered low-risk. If you join, doctors will check regularly to make sure the cancer does not grow or spread.
Hear when a new Papillary Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.